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BACKGROUND/PURPOSE: A new molecular classification scheme has recently been adopted that 
groups all enteroviruses into four species, designated human enterovirus A (HEV-A) through D. In this 
study, we tried to demonstrate the correlation between this molecular classification scheme and clinical 
manifestations in patients. 
METHODS: We retrospectively reclassified the clinical isolates of enteroviruses from the preceding 
4.5 years in our virology laboratory using reverse transcription-polymerase chain reaction, and reviewed 
the clinical manifestations of 138 pediatric patients.
RESULTS: We reclassified 23 isolates of the five serotypes into the HEV-A group, 110 isolates of 16 sero-
types into the HEV-B group, five isolates into the HEV-C group, and no isolate of the HEV-D group. 
HEV-A species caused significantly more hand-foot-and-mouth disease (p < 0.001), herpangina (p = 0.029), 
and myoclonic jerks (p < 0.001) compared with HEV-B species. However, HEV-B species caused signifi-
cantly more pharyngitis (p = 0.043), respiratory tract infections (p = 0.046), nausea and vomiting (p = 0.007), 
and aseptic meningitis (p = 0.001). The only death in our report was caused by coxsackievirus A16, which 
belonged to the HEV-A group.
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Introduction
Enteroviruses are common viruses associated with diverse 
clinical manifestations ranging from mild febrile illness, 
respiratory tract infection, acute gastroenteritis and asep-
tic meningitis, to severe and potentially fatal conditions 
including encephalitis, neonatal sepsis-like syndrome, 
and pulmonary edema after infection with enterovirus se-
rotype 71 (EV71).1 Many authors suggest that the disease 
severity of enterovirus infection is also associated with 
host factors such as patient age, gender,2 host cell mem-
brane receptors,3 and the environment, thus accounting 
for the greater prevalence of infections in children of lower 
socioeconomic class. The neutralization assay is usually 
used for enterovirus serotyping, but it is labor-intensive 
and time-consuming. Standardized antisera, which are 
in limited supply, have to be prepared for each serotype. 
Molecular typing based on reverse transcription-polymerase 
chain reaction (RT-PCR) has been recently developed to 
reduce the time required to type an enterovirus isolate and 
those isolates that are difficult or impossible to serotype.4,5 
More than 80 enterovirus serotypes can now be divided 
into four human enterovirus (HEV) species, designated 
HEV-A through D, based on homology within the RNA 
coding region for the capsid protein, VP1, which contains 
the major neutralization target (Table 1).6 The close rela-
tionship between polioviruses and HEV-C in the non-
capsid coding region indicates that they belong to the 
same species.7 In addition, rapid genomic evolution via 
recombination, deletion, and mutation among enterovi-
rus species may result in an inaccurate serotyping result 
because most antisera are produced using old prototypes 
of enteroviruses dating back to the 1950s or 1960s.8
None of the published studies have clearly demon-
strated a correlation between the virulence of each HEV 
species and clinical illness. In this study, we reviewed 
the clinical manifestations of hospitalized patients with 
enterovirus infections and compared the relationships 
between species-specific virulence and disease patterns. 
By establishing a clinical correlation, this new molecular 
classification may be an alternative method to serotyping 
for use in a clinical laboratory in certain circumstances 
CONCLUSION: The association between the molecular classification of enteroviruses and related 
disease patterns is an important finding. We suggest that this molecular classification could be applied in 
a clinical laboratory as an alternative method under certain circumstances, such as limited availability of 
antisera or questionable serotyping results, to identify the untypeable isolates.
KEYWORDS: aseptic meningitis, clinical manifestations, enteroviruses, molecular classification, RT-PCR
Table 1. Correspondence between human enterovirus species and previous serotypesa
 Previous serotypes
Species 
Coxsackievirus A Poliovirus Coxsackievirus B Echovirus Enterovirus
HEV-A CAV2–8, 10, 12, 14, 16 – – – EV71, 76, 89–92
HEV-B CAV9 – CBV1–6 E1–7, 9, 11–21,  EV69, 73–75, 77–88, 93, 
     24–27, 29–33  97, 98, 100, 101
HEV-C CAV1, 11(15), 13(18),  Poliovirus 1–3 – – EV95, 96, 99, 102
  17, 19–22, 24
HEV-D – – – – EV68, 70, 94
aData from the Taiwan Centers for Disease Control.6 HEV = Human enterovirus; CAV = Coxsackievirus A; CBV = Coxsackievirus B; E = Echovirus; 
EV = Enterovirus.
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such as limited availability of antisera, dubious serotyp-
ing results, or where serotyping is difficult or impossible. 
Furthermore, future antiviral therapies, vaccine develop-
ment, or other novel treatments could be developed, based 
on the results of this molecular classification.
Methods
Patient characteristics and virus isolation
One hundred and forty clinical enterovirus isolates from 
140 pediatric patients were identified in the Taipei 
Veterans General Hospital (VGHTPE) virology laboratory 
from January 2001 to June 2005. We retrospectively re-
viewed the medical charts of the 140 pediatric patients, 
who were treated in either VGHTPE or other rural hospi-
tals. Of the 140 isolates, 17 strains were untypeable and 
123 were typeable. To reduce the errors associated with 
conventional laboratory diagnostic methods, 50 of the 123 
typeable strains were randomly selected and reclassified 
using RT-PCR plus sequencing, revealing 100% compati-
bility. The 17 untypeable enteroviruses were also reclassi-
fied according to the PCR sequencing results.
During the 4.5 years of this study, 243 enterovirus 
isolates were originally identified by neutralization or im-
munefluorescence assay (IFA) in this virology laboratory. 
A total of 9,107 virus samples were sent to our laboratory 
within the study period, with an enterovirus isolation rate 
of 2.67%. Among them, only the 140 isolates from pediat-
ric patients (< 18 years of age) were subjected to analysis. 
The VGHTPE is a national medical center and teaching 
hospital with approximately 3,000 beds. The virology labo-
ratory receives approximately 2,000 clinical samples per 
year, including throat and rectal swabs, feces, serum, and 
cerebrospinal fluids collected from patients in local clin-
ics or hospitals in Taipei City and suburban areas with 
various infectious diseases.
RNA extraction and RT-PCR
Virus serotypes were identified by sequence analysis of the 
VP1 gene. For the initial testing, RNA was extracted using 
the QIAamp viral RNA mini kit (Qiagen Ltd., Crawley, UK) 
in accordance with the manufacturer’s recommendations.
A 50-μL reaction consisted of 10 μl of 5 × RT-PCR buffer 
(1 × buffer), 1.75 mM MgCl2, 800 μM dNTP mix, 5 mM 
DTT, 400 μM each forward (5-MIGCIGYIGARACNGG-3) 
and reverse (5-CICCIG GIGGIAYRWACAT-3) serotype-
specific primers,8,9 25 U MultiScript reverse transcriptase 
(Roche Ltd., Branchburg, NJ, USA), 2.5 U Ampli Taq Gold 
DNA polymerase (Applied Biosystems, Foster City, CA, 
USA), 10 U RNase inhibitor, and 8 μL of template RNA. 
The reactions were incubated at 42ºC for 30 minutes and 
then 94ºC for 3 minutes. Thermocycling was performed 
in a 9600 model thermocycler (Perkin-Elmer, Norwalk, 
Connecticut) with 35 cycles at 94ºC for 30 seconds, 42ºC 
for 30 seconds, and 60ºC for 30 seconds, followed by in-
cubation at 72ºC for 5 minutes. PCR products were sepa-
rated at 120 volts in a 1.5% agarose gel stained with 0.5 μg/
mL ethidium bromide for 60 minutes.
The Qiagen gel extraction kit (Qiagen) was used to ex-
tract the DNA from the agarose gels in accordance with 
the manufacturer’s recommendations. Both strands of the 
PCR amplicons were cycle-sequenced with rhodamine-
labeled dideoxynucleotide chain terminators (DNA se-
quencing kit; ABI) and analyzed on an ABI Prism 310 
automatic sequencer (Applied Biosystems, USA). PCR 
primers were used for the sequencing. The sequences were 
aligned with published enterovirus sequences obtained 
from GenBank.
Poorly-amplified strains were re-cultured with rhab-
domyosarcoma cells separately at 37ºC in 5% CO2, and 
the cytopathic effect (CPE) observed daily. When about 
60% CPE was evident, the tube was frozen at −70ºC and 
then re-amplified as described above.
Statistical analysis
The χ2 or Fisher’s exact test was used for contingency 
table analysis of the symptoms and signs associated with 
the different virus species. SPSS version 11 (SPSS Inc., 
Chicago, IL, USA) was used for the analysis and p < 0.05 
was considered statistically significant. 
Results
All 140 isolates were initially serotyped using neutraliza-
tion or IFA for the presence of a characteristic CPE. After 
RT-PCR reconfirmation using sequences alignment and 
after excluding two rhinoviruses, we were able to reclassify 
138 isolates into the categories HEV-A, -B, -C, or -D. 
RT-PCR and serotyping results were discordant for two 
isolates. Echovirus 31 (E31) was typed as E30 and E28 
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as E30. This may have been due to antigenic variation or 
viral aggregation during the cross-reaction.11
Samples from the 138 pediatric patients were analyzed. 
Seventy-three were sourced from our hospital (VGHTPE) 
and 65 from other medical facilities. We reclassified 23 
isolates of five serotypes into the HEV-A group, 110 iso-
lates of 16 serotypes into the HEV-B group, and five iso-
lates into the HEV-C group (Table 2). All five HEV-C 
isolates were polioviruses and were most likely due to oral 
polio vaccinations. No isolate was classified into the HEV-D 
group in this study. Since the number of isolates in the 
HEV-C group was small, we only compared the clinical 
manifestations of patients suffering from HEV-A or HEV-B 
infections to avoid inaccurate interpretations.
Enteroviruses in the HEV-B group accounted for the 
majority of infections in our study (79.7%), while entero-
viruses in the HEV-A group accounted for 16.7%. HEV-A 
caused significantly more hand-foot-and-mouth disease 
(p < 0.001), herpangina (p = 0.029) and myoclonic jerks 
(p < 0.001) compared with HEV-B. However, HEV-B caused 
significantly more pharyngitis (p = 0.043), respiratory tract 
infections (p = 0.046), nausea/vomiting (p = 0.007) and 
aseptic meningitis (p = 0.001). The two cases of encephalitis 
in the HEV-A group were both caused by serotype coxsack-
ievirus A16 (CAV16) and one patient eventually died. This 
was the only mortality.
Discussion
To the best of our knowledge, this is the first formal study 
comparing the biological behavior of enteroviruses in 
human disease based upon this new molecular classifica-
tion. It is not surprising that two of the enteroviruses pre-
viously classified using the former system were reclassified 
Table 2. Comparisons of the clinical manifestations of human enterovirus speciesa,f
Variable HEV-Ad (n = 23) HEV-Be (n = 110) pb HEV-Cc (n = 5)
Sex, male 12 (52.2) 64 (58.2)  0.766  4 (80.0)
Age (mo) 47.6 35.7 – 10.8
Hand-foot-and-mouth disease 11 (47.8) 2 (1.8) < 0.001 0 (0)
Herpangina 9 (39.1) 18 (16.4) 0.029 0 (0)
Respiratory tract infection 2 (8.7) 35 (31.8) 0.046 2 (40.0)
Acute pharyngitis 1 (4.3) 29 (26.4) 0.043 0 (0)
Vomiting/nausea 2 (8.7) 45 (40.9) 0.007 3 (60.0)
Diarrhea 0 (0) 11 (10.0) 0.243 3 (60.0)
Aseptic meningitis 1 (4.3) 47 (42.7) 0.001 1 (20.0)
Myoclonic jerk 4 (17.4) 0 (0) < 0.001 0 (0)
Convulsion 1 (4.3) 1 (0.9) 0.772 0 (0)
Encephalitis 2 (8.7) 3 (2.7) 0.444 0 (0)
Newborn sepsis-like syndrome 0 (0) 15 (13.6) 0.129 0 (0)
Death 1 (4.3) 0 (0) 0.385 0 (0)
aData presented as n (%); bcomparison of HEV-A group and HEV-B group; conly 5 isolates of HEV-C; dHEV-A included CAV2 (n = 1), CAV4 
(n = 2), CAV6 (n = 1), CAV16 (n = 18) and EV71 (n = 1); CAV16 (n = 4) contributed to all myoclonic jerks; CAV16 (n = 11) and EV71 (n = 1) 
caused hand-foot-and-mouth disease; CAV2 (n = 1), CAV4 (n = 1), CAV6 (n = 1), and CAV16 (n = 6) are associated with herpangina; CAV16 
(n = 2) were responsible for encephalitis; eHEV-B included 16 serotypes in our study: CAV9 (n = 2), CBV2 (n = 2), CBV3 (n = 51), CBV4 (n = 6), 
CBV5 (n = 8), E4 (n = 1), E5 (n = 1), E6 (n = 5), E7 (n = 3), E9 (n = 1), E11 (n = 6), E14 (n = 1), E19 (n = 2), E24 (n = 5), E30 (n = 14), and E31(n = 2); 
aseptic meningitis caused by the serotype CBV3 (n = 12), CBV4 (n = 1), CBV5 (n = 5), E6 (n = 4), E7 (n = 2), E11 (n = 2), E24 (n = 4), E30 (n = 14), 
and E31 (n = 2); sepsis-like syndrome caused by the serotype CBV3 (n = 10), CBV5 (n = 2), E6 (n = 1), E11 (n = 1), E14 (n = 1); the serotype CAV9 
(n = 1), CBV3 (n = 13), CBV4 (n = 1), CBV5 (n = 4), E5 (n = 1), E6 (n = 3), E7 (n = 2), E11 (n = 2), E24 (n = 4), E30 (n = 11), E31 (n = 2) were respon-
sible for nausea and vomiting; the serotype CBV3 (n = 4), CBV4 (n = 1), CBV5 (n = 2), E7 (n = 1), E11 (n = 1), E30 (n = 1), and E31 (n = 1) were 
responsible for diarrhea; the serotype CBV2 (n = 1), CBV3 (n = 10), CBV4 (n = 2), CBV5 (n = 4), E5 (n = 1), E6 (n = 2), E11 (n = 3), E24 (n = 2), 
E30 (n = 5), and E31 (n = 1) were responsible for respiratory tract infections; ftwo rhinoviruses were excluded from 140 previously isolated 
strains. HEV = Human enterovirus.
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as rhinoviruses. Along with enteroviruses and several other 
virus genera, human rhinoviruses belong to the family 
Picornaviridae, which share many common features in-
cluding a non-enveloped icosahedral capsid, a messenger-
sense RNA genome, and partial nucleotide and amino 
acid sequence homology.12 Also, two isolates were reclassi-
fied because their serotyping was discordant with the con-
ventional diagnostic method, possibly due to antigenic 
variations or viral aggregation during cross-reaction.11
Our findings confirm previous study results, with the 
serotype CAV16 accounting for the majority of infections 
involving HEV-A (18/23 HEV-A isolates were serotype 
CAV16; 78.3%). Furthermore, the strain is known to be the 
major cause of hand-foot-and-mouth disease, herpangina 
and, rarely, meningitis. The only death in our study was 
caused by CAV16. In the literature, however, CAV16 is 
rarely associated with a fatal outcome, whereas another 
HEV-A member, EV71, caused many deaths in the Malaysian 
and Taiwanese outbreaks in 1997–2000.13,14 The two sero-
types usually co-circulate within a given geographical area 
and result in similar clinical manifestations, such as hand-
foot-and-mouth disease. Further study is required to estab-
lish whether the fatality was due to recombination between 
the two HEV-A members resulting in the exchange of vir-
ulent sequences, or just a sporadic event. In our study, 
four patients had myoclonic jerks, which were all caused 
by serotype CAV16. HEV-A also included the less common 
serotypes CAV2, CAV4 and CAV6, all of which are associ-
ated with herpangina and respiratory tract diseases.
The HEV-B species accounted for the highest percentage 
of studied cases (79.7%). A recent, comprehensive survey 
of enteroviruses conducted in the United States shows 
that these serotypes belong to HEV-B and account for 
many human diseases worldwide.15 In the present study, 
a marked number of patients suffered from aseptic men-
ingitis caused by HEV-B group viruses (47/110 patients 
of HEV-B group isolates; 42.7%). The most common 
serotypes causing aseptic meningitis in our study were 
E30 (14 patients) and coxsackievirus B3 (CBV3; 12 pa-
tients). This result is similar to that reported in previous 
studies.16–19
Gastrointestinal symptoms such as vomiting are sig-
nificantly more prominent in HEV-B infected patients. 
As we know, coxsackieviruses and echoviruses replicate in 
the small bowel, and they are frequently cited as causes 
of nonbacterial diarrhea or gastroenteritis. Outbreaks of 
E11, E14 and E18 have occasionally been responsible for 
epidemic diarrhea in young infants.20 However, in our 
report, episodes of diarrhea resulting from enterovirus 
infection were not frequent (occurring in 9.7% of HEV-B 
infected patients). In fact, conflicting results regarding 
the rate of enterovirus isolation from children with acute 
diarrheal illness and matched healthy control children 
have been reported.21
Our study also showed that HEV-B species tended to 
be the dominant pathogens in neonatal sepsis-like syn-
drome, although this was not statistically significant. Early 
descriptions of coxsackievirus B group viruses in neonatal 
disease came from outbreaks in nurseries in South Africa, 
Zimbabwe and the Netherlands.22 Many nursery outbreaks 
of neonatal echovirus infection have been recorded, with 
the severity of neonatal disease varying according to the viral 
serotype.23 Neonates are uniquely susceptible to coxsackie-
virus and echovirus diseases. Although many enterovirus 
serotypes can still cause self-limiting clinical syndromes 
in neonates, some serotypes are capable of producing ful-
minant and frequently fatal diseases in this patient group. 
CBV2–5 and E11 are most frequently associated with 
overwhelming systemic neonatal infections.20,24
One of the limitations of our study is that none of the 
HEV-C (except for poliovirus) or HEV-D viruses were iso-
lated in our laboratory. As we know, in most studies the 
isolation rate for CAVs is probably an underestimation. It 
has been shown that the growth of CAVs is somewhat prob-
lematic in most cell lines (except for CAV9 and CAV16). 
The efficacy of suckling mice for the isolation of difficult-to-
cultivate CAVs has been reported in a number of studies.25 
This may account for the relatively few HEV-A cases and 
the lack of HEV-C isolates in our virus pool. A new diag-
nostic method is needed to overcome this problem.
Other major limitations of our study are its retrospec-
tive design and the reliance on reviews of medical records 
from different hospitals. This may increase the likelihood 
of variation in descriptive medical terminology and clas-
sification. In addition, the imperfections that are inherent 
in conventional cultural diagnostic methods suggest that 
some serotypes and species may have been underestimated. 
It appears prudent to suggest that a large prospective sur-
vey utilizing the latest diagnostic laboratory methods is 
required for further elaboration of our findings.
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In conclusion, if the correlation of genotyping and 
clinical manifestations can be confirmed by future stud-
ies, we suggest that this method of molecular classifica-
tion could be applied (under certain circumstances) in a 
clinical laboratory as an alternative to serotyping. The ad-
vantages of this molecular classification method are that 
it is less labor-intensive and less time-consuming, without 
the need to prepare all the standardized antisera and the 
ability to type enteroviruses that are untypeable using 
neutralization or IFA. 
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